Supplementary Figure 7 from Identification of a Novel Inflamed Tumor Microenvironment Signature As a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Jeffrey S. Damrauer,Kyle R. Roell,Markia A. Smith,Xuezheng Sun,Erin L. Kirk,Katherine A. Hoadley,Halei C. Benefield,Gopakumar Iyer,David B. Solit,Matthew I. Milowsky, William Y. Kim,Matthew E. Nielsen,Sara E. Wobker,Guido Dalbagni,Hikmat A. Al-Ahmadie,Andrew F. Olshan,Bernard H. Bochner, Helena Furberg,Melissa A. Troester, Eugene J. Pietzak

crossref（2024）

引用 0|浏览1

暂无评分

摘要

Supplemental Figure 7 shows PDL1 (CD274) Expression, PD1 (PDCD1) Expression, and CTLA4 Expression by UROMOL Subclasses in MSK and UNC cohorts and RFS (by high, medium, low tertiles) in MSK, UROMOL, & Northwestern Cohorts.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要